Antihypertensive
7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
    1.
    发明授权
    Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones 失效
    抗高血压7-〔2-(二烷基氨基)乙基〕-4-羟基-1,3-苯并咪唑-2-酮

    公开(公告)号:US4554287A

    公开(公告)日:1985-11-19

    申请号:US649465

    申请日:1984-09-12

    CPC classification number: C07D235/26 Y02P20/55

    Abstract: 7-[2-Dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones are prepared by oxidative cyclization of a urea, followed by removal of protective groups. The compounds are D.sub.2 -agonists and, thereby, have anti-hypertensive activity. A species of the group is 7[2-N,N-di-n-propylamino)ethyl]-4-hydroxyl-1,3-benzimidazol-2-one.

    Abstract translation: 7- [2-二烷基氨基)乙基] -4-羟基-1,3-苯并咪唑-2-酮通过氧化环化脲制备,然后除去保护基团。 化合物是D2-激动剂,因此具有抗高血压活性。 该基团是7 [2-N,N-二正丙氨基)乙基] -4-羟基-1,3-苯并咪唑-2-酮。

Patent Agency Ranking